# Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC)

> **NCT05784142** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Jiangsu Cancer Institute & Hospital** · enrollment: 55 (estimated)

## Conditions studied

- Lung Cancer, Non-small Cell

## Interventions

- **RADIATION:** hypofractionated radiation therapy

## Key facts

- **NCT ID:** NCT05784142
- **Lead sponsor:** Jiangsu Cancer Institute & Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-10-27
- **Primary completion:** 2024-12
- **Final completion:** 2027-12
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2023-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05784142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05784142, "Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05784142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*